Expression of TGF-α and EGFR in breast cancer and its relation to angiogenesis

Breast Journal

Volumn 6, Issue 3, 2000, Pages 171-177

  Soares, Raquel ^a   Pereira, Mónica Botelho ^a   Silva, Cláudia ^a   Amendoeira, Isabel ^b   Wagner, Roberto ^a   Ferro, Josefo ^a   Schmitt, Fernando Carlos ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Angiogenesis; Breast cancer; EGFR; Immunohistochemistry; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER SIZE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROGNOSIS;

EID: 0034076920     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2000.98046.x     Document Type: Article

References (33)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Marinho A, Soares R, Schmitt FC. Angiogenesis in breast cancer is related to age but not to other prognostic parameters. Pathol Res Pract 1997;193:267-73.
3. Reif M, LeJeune S, Scott PAE, et al. Expression of the angiogenic factors, vascular endothelial cell growth factor, acidic and basic growth factor, tumor growth factor β-1, platelet-derived endothelial cell growth factor, placenta growth fac-tor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997;57:963-69.
4. Derynck R. Transforming growth factor α. Cell 1988; 54:593-95.
5. Lupu R, Wellstein A, Sheridan J, et al. Purification and characterisation of a novel growth factor from human breast cancer cells. Biochemistry 1992;31:7330-40.
6. Bebók Z, Markus B, Nimeth P. Prognostic relevance of transforming growth factor alpha (TGFα) and tumor necrosis factor alpha (TNFα) detected in breast cancer tissues be immunohistochemistry. Breast Cancer Res Treat 1994;29:229-35.
7. Auvinen P, Lipponen PK, Kataja W, Johansson RT, Syrjanen KJ. Prognostic significance of TGF-α expression in breast cancer. Acta Oncol 1996;35:995-98.
8. Gille J, Swerlick RA, Caughman SW. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPFATEGF) gene requires AP-2-dependent DNA binding and transactivation. EMBO J 1997; 16:750-59.
9. Martinazzi M, Crivelli F, Zampatti C, et al. Epidermal growth factor receptor immunohistochemistry in different histological types of infiltrating breast carcinoma. J Clin Pathol 1993;46:1009-110.
10. Ciardello F, Damiano V, Bianco R, et al. Antitumour activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst 1996;88:1770-76.
11. Toi M, Nakamura T, Mukaida H, et al. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer 1990;65:1980-84.
12. Petit AM, Rak J, Hung MC, et al. Neutralising antibodies against epidermal growth factor and erb-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Am J Pathol 1997;151:1523-30.
13. Goldman CK, Kim J, Wong WL, et al. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 1993;4:121-33.
14. World Health Organization. Histological typing of breast tumors, 2nd ed. Geneva: World Health Organization, 1981.
15. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: experience from a large study with long term follow-up. Histopathology 1991;19:403-10.
16. De Jong JS, van Diest PJ, van Der Valk P, et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I. An inventory in search of autocrine and paracrine loops. J Pathol 1998;184:44-52.
17. Miliaris D, Kamas A, Kalekou H. Angiogenesis in invasive breast carcinoma: Is it associated with parameters of prognostic significance? Histopathology 1995;26:165-69.
18. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1992;84: 1875-87.
19. Sannino P, Shousha S. Demonstration of estrogen receptors in paraffin wax sections of breast carcinoma using monoclonal antibody 1D5 and microwave oven processing. J Clin Pathol 1994;47:90-92.
20. Schmitt FC, Leal C, Lopes C. p53 expression and nuclear DNA content in breast intraductal proliferations. J Pathol 1995;176:233-41.
21. Schmitt FC, Ferreira MP. MIB-1 is a suitable marker of proliferative activity in formalin fixed paraffin-embedded sections of breast cancer. Int J Surg Pathol 1995;2:287-94.
22. Soares R, Marinho A, Schmitt FC. Expression of syalil-Tn in breast cancer: correlation with prognostic parameters. Pathol Res Pract 1996;192:1181-86.
23. Wright C, Angus B, Nicholson S, et al. Expression of c-erbB2 oncoprotein: a prognostic indicator in human breast cancer. Cancer Res 1989;49:2087-90.
24. Saji S, Toi M, Tominaga T. The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer. Nippon Geka Gakkai Zasshi 1996;97:368-74.
25. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α, a more potent angiogenic mediator than epidermal growth factor. Science 1984;226:705-7.
26. Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathways by distinct integrins. Science 1995;270:1500-502.
27. Schmitt FC, Figueiredo P, Lacerda M. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis. Virchows Arch 1995;427:251-58.
28. Gagliardi A, Collins DC. Inhibition of angiogenesis by antiestrogens. Cancer Res 1993;53:533-35.
29. Nicholson S, Richard J, Sainsbury C, et al. Epidermal growth factor receptor: results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br J Cancer 1991;63:146-50.
30. De Jong JS, van Diest PJ, van Der Valk P, et al. Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. II. Correlations with proliferation and angiogenesis. J Pathol 1998;184:53-57.
31. Pfeiffer D, Spranger J, Al-Deiri M, et al. MRNA expression of ligands of the epidermal growth factor receptor in the uterus. Int J Cancer 1997;72:581-86.
32. Ciardello F, Kim N, Saeki T, et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 1991;88:7792-96.
33. Eckhardt SG, Pluda GM. Development of angiogenesis inhibitors for cancer therapy. Invest New Drugs 1997;15:1-3.